Mind Over Matter: BCI Pioneer John Donoghue Wins Top Engineering Prize

BOSTON, MA – February 05, 2026 – John Donoghue, Ph.D., a pioneering neuroscientist and board director at PathMaker Neurosystems, has been named a laureate of the 2026 Queen Elizabeth Prize for Engineering (QEPrize), one of the world's most prestigious honors for innovation. The award recognizes his foundational work in developing brain-computer interfaces (BCIs) that are restoring movement and communication to people with paralysis.

The prize, announced in London on February 3, celebrates Donoghue's role in creating the BrainGate system, a technology that translates thought into action. This recognition places him among a select group of engineers whose work has profoundly benefited humanity, highlighting a new era where the lines between mind, body, and machine are being redrawn.

The Engineer Who Unlocked the Mind

At the heart of this prestigious award is decades of visionary research conducted in Professor Donoghue’s lab at Brown University. As the H.M. Wriston Professor of Neuroscience and Engineering, Donoghue has dedicated his career to understanding the complex neural codes that govern movement. His work challenged the long-held belief that the brain's motor cortex goes silent after a spinal cord injury or in the face of diseases like Amyotrophic Lateral Sclerosis (ALS).

Donoghue and his team proved that even years after an injury, the brain continues to generate intricate signals for movement. The challenge was to capture and decode them. The result was BrainGate, a revolutionary BCI system. A tiny sensor implanted in the motor cortex reads the neural activity associated with intended movements. Sophisticated software then decodes these signals in real-time, translating them into digital commands that can control external devices.

For individuals with paralysis, the impact has been life-altering. Clinical trial participants using BrainGate have been able to move a computer cursor, type emails, operate a robotic arm to drink a cup of coffee, and regain a tangible connection to the world around them—all by thinking.

“It is a profound honor to receive this award, and I hope it inspires the next generation of scientists and entrepreneurs to push boundaries and build technologies that meaningfully improve the lives of others,” said John Donoghue upon receiving the news.

A Prize for Humanity's Benefit

The Queen Elizabeth Prize for Engineering is often referred to as the Nobel Prize of the engineering world. It is awarded not just for a clever invention, but for ground-breaking innovation with a demonstrated global impact. Past winners include the creators of the internet, GPS, and digital imaging sensors—technologies that have fundamentally reshaped modern society.

The 2026 prize was awarded under the theme of "Modern Neural Interfaces," recognizing a cohort of nine engineers who have collectively transformed the field. Alongside Donoghue, the laureates include pioneers of cochlear implants like Blake Wilson and Graeme Clark; developers of deep brain stimulation, Alim Benabid and Pierre Pollak; and Grégoire Courtine and Jocelyne Bloch, whose work on electronic spinal stimulation helps restore locomotion.

Professor Dame Lynn Gladden, Chair of the QEPrize Judging Panel, noted that modern neural interfaces exemplify “engineering at its most powerful, translating deep scientific understanding into practical solutions that restore essential human functions.” The award acknowledges that these once-futuristic concepts are now a clinical reality, offering hope to millions.

From Lab Bench to Patient Hope

Professor Donoghue’s influence extends beyond academic research into the clinical and commercial realms, where scientific breakthroughs are translated into patient solutions. His role as a Board Director at PathMaker Neurosystems underscores this commitment. The Boston-based company is at the forefront of developing treatments for complex neurological disorders, most notably ALS.

PathMaker's flagship technology, the MyoRegulator® platform, represents a different but complementary approach to tackling neurological disease. It is a non-invasive system based on multi-site direct current stimulation, designed to treat the debilitating symptoms of ALS. The technology has already earned a coveted “Breakthrough Device Designation” from the U.S. Food and Drug Administration (FDA), a status intended to expedite the development and review of treatments for life-threatening conditions.

The association with a QEPrize laureate like Donoghue provides immense validation for the company's mission. It bridges the world of pioneering, invasive BCI research with the development of non-invasive neuromodulation therapies, suggesting a multi-pronged technological assault on neurological disease.

“PathMaker Neurosystems is honored to have Prof. Donoghue as a member of its Board of Directors,” said Nader Yaghoubi, M.D., Ph.D., Co-Founder and Chief Executive Officer of PathMaker. “We extend our congratulations to Prof. Donoghue on this achievement and thank him for his extraordinary contributions to the neurotechnology field.”

The Expanding Frontier of Neurotechnology

The work of Donoghue and his fellow laureates represents a paradigm shift in medicine, one where engineering provides solutions for conditions once deemed untreatable. For patients with ALS, spinal cord injury, stroke, and other devastating disorders, these advancements are not abstract scientific achievements; they are the tangible seeds of hope for regaining independence and quality of life.

Technologies like BrainGate and the spinal stimulation systems developed by Courtine and Bloch are demonstrating that paralysis may not be a permanent state. They are part of a growing movement that views the nervous system as an electrical circuit that, when damaged, can be bypassed, re-routed, or reactivated with sophisticated engineering.

As fellow laureate Grégoire Courtine stated, the prize is “not the end of the journey, but the responsibility—and the encouragement—to continue the fight against paralysis.” This sentiment captures the forward momentum of a field that is just beginning to realize its full potential. The recognition of these pioneers by the QEPrize signals to the world that the age of neurorestoration has truly begun, promising a future where technology can mend the most complex system of all: the human nervous system.